Abstract
A series of prostaglandins selective for the human FP receptor have been synthesized and evaluated as potential therapeutics for the treatment of osteoporosis. The compounds proved to be potent (nanomolar binding affinity) and selective (>100x) ligands for the human FP receptor in vitro, and increased bone volume in the ovariectomized rat in vivo.
Cite
CITATION STYLE
Soper, D. L., Wang, Y., De, B., DeLong, M. A., Dirr, M. J., Soehner, M. E., … Wos, J. A. (2002). The Design and Synthesis of Selective Prostaglandin Analogs as Bone Anabolic Agents for the Potential Treatment of Osteoporosis. In Advances in Experimental Medicine and Biology (Vol. 507, pp. 303–307). Kluwer Academic/Plenum Publishers. https://doi.org/10.1007/978-1-4615-0193-0_46
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
